Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 153,192 | 180,002 | 227,460 | 73,997 | 66,579 |
| Marketable Securities | 94,809 | 110,704 | 119,927 | 140,556 | 176,221 |
| Receivables | N/A | N/A | 1,250 | 1,251 | 2,604 |
| TOTAL | $263,250 | $303,628 | $358,811 | $224,555 | $251,978 |
| Non-Current Assets | |||||
| PPE Net | 19,066 | 17,938 | 17,355 | 15,047 | 13,580 |
| Investments And Advances | 1,401 | 1,896 | 7,938 | 17,029 | 31,149 |
| Other Non-Current Assets | 36,172 | 31,397 | 12,189 | 13,017 | 8,988 |
| TOTAL | $56,639 | $51,231 | $37,482 | $45,093 | $53,717 |
| Total Assets | $319,889 | $354,859 | $396,293 | $269,648 | $305,695 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,791 | 13,735 | 8,623 | 5,450 | 4,879 |
| Accrued Expenses | 48,278 | 45,094 | 48,900 | 18,913 | 13,153 |
| TOTAL | $82,359 | $82,258 | $94,591 | $56,165 | $47,863 |
| Non-Current Liabilities | |||||
| Long Term Debt | 50,437 | 24,643 | 16,117 | 19,036 | 21,872 |
| Deferred Revenues | 20,441 | 16,819 | 21,624 | 19,829 | 21,242 |
| Other Non-Current Liabilities | 24,254 | 29,453 | 20,434 | 14,947 | 9,971 |
| TOTAL | $156,574 | $141,094 | $125,964 | $112,417 | $114,127 |
| Total Liabilities | $238,933 | $223,352 | $220,555 | $168,582 | $161,990 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,612 | 4,601 | 4,592 | 4,586 | 4,581 |
| Common Shares | 92 | 92 | 92 | 92 | 92 |
| Retained earnings | -670,978 | -614,354 | -564,353 | -632,571 | -584,241 |
| Other shareholders' equity | -215 | -60 | 11 | 12 | -15 |
| TOTAL | $80,956 | $131,507 | $175,738 | $101,066 | $143,705 |
| Total Liabilities And Equity | $319,889 | $354,859 | $396,293 | $269,648 | $305,695 |